Trials / Completed
CompletedNCT04714385
Medtronic PSR TDD PMCF
Product Surveillance Registry (PSR) - Targeted Drug Delivery (TDD) - SynchroMed II European Post-Market Clinical Follow-up (PMCF)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 209 (actual)
- Sponsor
- Medtronic · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide continuing evaluation and reporting of safety and performance of the SynchroMed II Infusion System within its intended use. Data will support post-market surveillance obligations.
Detailed description
This study was originally posted under NCT01524276 and now posted alone to adapt to new ISO regulation.
Conditions
Timeline
- Start date
- 2017-02-09
- Primary completion
- 2024-01-18
- Completion
- 2024-01-18
- First posted
- 2021-01-19
- Last updated
- 2024-06-04
Locations
15 sites across 8 countries: Belgium, Czechia, France, Netherlands, Slovenia, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT04714385. Inclusion in this directory is not an endorsement.